Cancer Science & Therapy

This Expert Level Scientific Award is given to the renowned scientific personnel who have contributed their services with a passion, dedication and commitment for the human development and distinguished experts who have made significant, sustained and continuing contributions in the field of Cancer Therapeutics. It is considered as the most esteemed award of the entire conference. His/Her contribution could be long-term, cumulative or single, particularly insightful, experimental, applicable, or interpreted ideas.

Conference series is organizing Cell Signaling conference in 2020 in London, UK. This conference will explore the advances in Cell Signaling Technologies, Cell Metabolism, Medical Approaches, Oncology, Translational Oncology, Computational Technologies, etc.

The cell signaling market is projected to reach USD 3.51 billion by 2022 from USD 2.53 billion in 2017, at a CAGR of 6.8%. The term “cell signaling” is used to define the complex interactive system of signals that regulates and mediate various cellular responses in the human body.

The convention highlights the subject “New Innovations in prevention of Cancer”. Cancer Genomics 2020 will speak the ultra-present day studies consequences and technological improvements in the area of Cancer Genomics, Cancer Epigenomics & Metagenomics, Cancer Immunogenomics, Hereditary Cancer Syndromes, Genomics of Adult and Pediatric Cancers, Systems Biology and Drivers of Cancer, Structural Genomics and Cancer, Etiology-Specific Genomic Alterations, Cancer Biomarkers, Genome-Based Cancer Typing.

Breast and Cervical Cancer: Genes hold the protein-making instructions that do a lot of work in our cells. Some variations in genes can cause cells to avoid normal controls of growth and cancer. Many cancer-causing gene changes, for example, increase the development of a protein that allows cells to grow. Some result in a mistake being made, and thus non-functional, type of a protein that normally repairs cellular damage.

The global cancer therapeutics market size was valued at $98,900 million in 2018 and is estimated to reach at $180,193 million by 2026, registering a CAGR of 7.7% from 2019 to 2026. Cancer therapeutics involves the use and administration of chemotherapy and oncology drugs to treat cancer. Worldwide cancer affects more than 10 million people each year and the incidence of cancer is expected to increase by 2.4% annually to reach 14 million per year by 2020. Cancer is the second most common death in the industrialized world.

Global Cancer 2020 invites research scholars & young scientists, to submit the nominations for Young Scientist Awards: Global Cancer 2020. This Global Cancer 2020 Young Scientist Awards will be announced at the upcoming “4th Global Summit on Cancer” at Tokyo, Japan this November 11-12, 2020.

Cancer Summit 2020 invites research scholars & young scientists, to submit the nominations for Young Scientist Awards: Cancer Summit 2020. This Cancer Summit 2020 Young Scientist Awards will be announced at the upcoming “2nd Asia Pacific Oncology and Cancer Conference” at Tokyo, Japan this December 07-08, 2020.

16th International Conference on Breast Pathology and Cancer Diagnosis organized during May 10-11, 2019 at Montreal, Canada. With the support and contribution of the Organizing Committee Members, we successfully hosted the event at the conference venue.

Asian Breast Cancer 2020 invites research scholars & young scientists, to submit the nominations for Young Scientist Awards: Asian Breast Cancer 2020. This Asian Breast Cancer 2020 Young Scientist Awards will be announced at the upcoming 11th Asian Breast Cancer: Screening, Treatment & Management Summit at Brisbane, Australia this November 2020.

Women’s health 2020 is designed to meet the needs of both experienced and new career professionals. It would be a gathering of experts from women’s health and Cancer across the globe. Women’s health Conference will provide great exposure to the new findings in the field of Women’s health. It is a wonderful opportunity for all to explore international networking and collaborate with world-class professionals where we wish to have your gracious presence in our platform.

The award is to the experts who have made outstanding contributions to advancing in Women’s health. It is the most prestigious award of the conference and tagged as a Scientific Service Achievement award. The eligibility criteria for achieving this award is that one should have a minimum of 20+ years of experience in the relative field in the public or private sector.

Women health refers to the health problems that are unique to a women anatomy such as issues related to pregnancy, menopause, and female organs. Even though slightly less than half of the world's population is female, historically medical research neglect the health needs of women, other than reproductive issues due to gender-differentiated access to medical treatment.

Breast Pathology 2020 invites scholars, researchers, academicians, students and corporate entities across the globe to join at the 18th International Conference and Expo on Breast Pathology & Cancer Diagnosis (Breast Pathology 2020) during March 23-24, 2020 in Madrid, Spain. The conference focuses on theme: “Early detection is the minimal way”.

With support of the Editorial Board Members of the respective Journals, Young and brilliant researchers from all over the 195 countries, we successfully completed 13th World Cancer Congress, which was held in Paris, France with the theme having “Assemble to Explicate and Terminate cancer”. The conference proceeded through various interesting Scientific Sessions and the following keynote lecturers by the eminent professionals.

Expert Level (Scientific Service Achievement Award) The award to the experts who have created outstanding contributions to advancing in oncology, it is the foremost prestigious award of the entire conference and is labeled as scientific service achievement award. The eligibility criteria for achieving this award is that one should have minimum of 20+ years of expertise within the relative field in public or non-public sector.

Cancer is a group of diseases caused by changes in DNA that alter cell behavior, causing uncontrollable growth and malignancy. Genomics is the study of the sequence of these letters in your DNA and how each string of letters passes information to help each cell in your body work properly. Cancer diagnosing begins with a radical physical communication and a whole anamnesis. Laboratory studies of blood, urine, and stool will sight abnormalities which will indicate cancer.

Breast Pathology 2020 aims to discuss the wonders happening in the ever growing field of Pathology. This conference is an acting stage for business professionals, Pathologists, Directors, academicians, technicians and mainly students to showcase their innovations and new ideas. Breast Pathology 2020 will have more than 50 International renowned speakers to share their latest research results to participants; the planned program will cover a variety of subjects in the field of Pathology.

The award to the experts who have made outstanding contributions to advancing in the field of Breast Pathology. It is the most prestigious award of the whole conference and is tagged as scientific service Achievement award. The eligibility criteria for achieving this award is that one should have minimum of 20+ years of experience in the relative field in public or private sector. The receiver of this award should have a dedicated fascination and should take initiative in researching the recent trends and developments towards the related subjects. You can nominate deserving of the award through online.

The International Global Cancer 2020 market is consider being worth $9.9 billion presently, and is expected to bench a value of $14.1 billion by 2025. The drugs driving this growth include once-daily LABA/LAMA fixed-dose combinations such as QVA-149, umeclidinium bromide and olodaterol.

The “3rd Global Summit on Oncology & Cancer” hosted by the Conference Series was held during May 6-7, 2019 in Tokyo, Japan with the theme “New Chemotherapeutic Approaches for Treatment of Cancer” for investigators across the globe to meet and perceive new scientific innovations.

Conference Series is organizing “4th Global Summit on Cancer” which is going to be held during November 11-12, 2020 at Tokyo, Japan. The theme of the conference is “Innovative Approaches and Research in Cancer”. The conference will cover the fields related to Cancer Treatments and Therapy, Cancer Immunology and Immunotherapy, Cancer Awareness and Survival, Oncology Nursing and Care and Cancer, its complication and the management.